The Oncotarget writers located that longitudinal modifications of HPV16 ctDNA relate to treatment action and additionally that ctDNA feedbacks are observed earlier than basic imaging. One of the most investigated ctDNA biomarker in HPV OPSCC is HPV ctDNA. No research study has really prospectively had a look at the capability of HPV ctDNA changes throughout the training course of treatment to forecast treatment result.
The Oncotarget authors located that longitudinal modifications of HPV16 ctDNA attach with treatment feedback and furthermore that ctDNA comments are observed earlier than basic imaging. The most investigated ctDNA biomarker in HPV OPSCC is HPV ctDNA.
